Brookline initiated coverage of Immunic with a Buy rating and $10 price target. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on IMUX: Immunic receives notice of allowance from USPTO Immunic, Inc. Is Worried About This – Should You Be Worried Too? Immunic Releases Insightful Investor Presentation Online IMUX Earnings Report this Week: Is It a Buy, Ahead of Earnings? Immunic files to sell 55.94M shares of common stock for holders